Home › Studies › PRJNA768409
PRJNA768409 SRP339901

Ulcerative colitis FMT donor & patient gut metagenomes (US)

Metagenomic sequencing of UC patients subjected to FMT and FMT-donors

59 fecal metagenome samples from a US fecal microbiota transplantation (FMT) study in active ulcerative colitis patients, collected before and 4 weeks after FMT, plus samples from the 2 donor fecal preparations used. machine-written summary

59 samples · 59 runs · US · Age unknown · 2021 · 22.04 Gbp / sample

Sources
✓Sequence archive 470✓Abstract / description 40○Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive470 sample values (collection date, country, health condition, health condition detail, intervention, latitude, location region, longitude)
✓ Abstract / description40 sample values (health condition, health condition detail)
○ Full textread; no usable statement or table · PMC8678328
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Faecal microbiota transplantation design single_arm_before_after · population ulcerative_colitis · Fecal microbiota transplantation, 2-donor preparation, sampled pre- and week 4 post-FMT

“before fecal microbiota transplantation (FMT)” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
unknown59
Condition
ulcerative_colitis59
Country
US59
Body site
primary59
Collected 2015–2016
2015: 14 samples2016: 25 samples20152016
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 51 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 8 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 22.04 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinalFMT donor → recipient

19 of 20 people sampled more than once (38 samples; median 2, up to 2 per person) · follow-up median 41 d (max 56 d) · median interval between samples 41 d (time from collection dates).

Patient_1Patient_1: day 0Patient_1: day 56Patient_10Patient_10: day 0Patient_10: day 48Patient_11Patient_11: day 0Patient_11: day 45Patient_12Patient_12: day 0Patient_12: day 48Patient_19Patient_19: day 0Patient_19: day 48Patient_2Patient_2: day 0Patient_2: day 27Patient_21Patient_21: day 0Patient_21: day 41Patient_24Patient_24: day 0Patient_24: day 41Patient_25Patient_25: day 0Patient_25: day 41Patient_27Patient_27: day 0Patient_27: day 41Patient_28Patient_28: day 0Patient_28: day 41Patient_29Patient_29: day 0Patient_29: day 47Patient_3Patient_3: day 0Patient_3: day 27Patient_31Patient_31: day 0Patient_31: day 35Patient_33Patient_33: day 0Patient_33: day 27Patient_4Patient_4: day 0Patient_4: day 27Patient_5Patient_5: day 0Patient_5: day 27Patient_6Patient_6: day 0Patient_6: day 27Patient_7Patient_7: day 0Patient_7: day 270 d14 d28 d42 d56 d

Each row is one person (19 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Faecalibacterium 10.8%Bacteroides 8.6%Roseburia 8.0%Blautia_A 7.1%Phocaeicola 5.3%Bifidobacterium 4.1%Ruminococcoides 3.6%Alistipes 2.9%Gemmiger 2.7%Collinsella 2.5%Anaerostipes 2.0%Fusicatenibacter 1.7%not assigned to a genus 4.9%other genera 36.0%

Genera, mean relative abundance over 51 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country59 100%59
health_condition59 100%3920
subject_id39 66%39
detailed_location59 100%
health_condition_detail59 100%3920
latitude59 100%59
location_region59 100%59
longitude59 100%59
collection_date39 66%39
intervention39 66%39
timepoint_label39 66%39
Papers (1)
  • Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation. 2022 PMID 34606847 PMC8678328 own_data
Details
Archive description

Fecal samples were collected from 20 patients diagnosed with active ulcerative colitis (UC, Mayo score >= 3 and an endoscopic subscore >= 1) before fecal microbiota transplantation (FMT) and at week 4 post-FMT. Samples from the 2-donor fecal preparation used to treat the 20 UC patients were also collected and subjected to metagenomic shotgun sequencing.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.65. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site study.description · “Fecal samples were collected from 20 patients”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN22039206collection_date2015-08-27R10.90biosample.attribute:collection_date2015-08-27
SAMN22039205countryUSR10.90sample.attr.geo_loc_nameUSA
SAMN22039206health_conditionulcerative_colitisR10.90biosample_attrUC
SAMN22039205health_conditionulcerative_colitisR40.50study.descriptionpatients diagnosed with active ulcerative colitis
SAMN22039206health_condition_detailUCR10.90sample.attr.host_diseaseUC
SAMN22039205health_condition_detailactive ulcerative colitis, Mayo score >= 3, endoscopic subscore >= 1R40.50study.descriptionactive ulcerative colitis (UC, Mayo score >= 3 and an endoscopic subscore
SAMN22039206interventionno_interventionR10.70sample.name_rule:source_material_idPatient.1.PRE
SAMN22039205latitude40.7655R10.90biosample.attribute:lat_lon40.7655 N 73.9550 W
SAMN22039205location_regionNew YorkR10.60biosample.attribute:lat_lon40.7655 N 73.9550 W
SAMN22039205longitude-73.9550R10.90biosample.attribute:lat_lon40.7655 N 73.9550 W
SAMN22039206subject_idPatient_1R10.70sample.name_rule:source_material_idPatient.1.PRE
SAMN22039206timepoint_labelbaselineR10.70sample.name_rule:source_material_idPatient.1.PRE
Sequencing

59 runs over 59 samples · mean 22.71 Gbp per run (median 22.04 Gbp, total 1,339.98 Gbp; 59 runs with a base count) · layout PAIRED 59 · platform ILLUMINA 59 · models Illumina HiSeq 2500 (59) · 86% of runs with a Sandpiper profile · first public 2021-11-01

Authors (0)

No author record.

Downloads

PRJNA768409.csv.gz (2.6 KB) · parquet (72.8 KB) — all 59 samples, every field with route and confidence · PRJNA768409_determinations.csv.gz (4.1 KB) — 510 evidence rows

Samples (59 · every field this project has values for · hover a cell for its source)
Loading the sample table…